The Effect of Magnesium Sulfate in Comparison to Opioids in the Management of Renal Colic that is Unresponsive to Non-Steroidal Antiinflammatory Drugs

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202406502996650

Enrollment

116

Registered

2024-06-11

Start date

2023-10-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urological and Genital Diseases Kidney Disease

Interventions

Magnesium sulphate

Naluphine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Clinically diagnosed Renal colic Not responding to NSAIDs

Exclusion criteria

Exclusion criteria: Cardiac or renal disease. Respiratory rate < 12 BpM. Systolic blood pressure < 100. Hypersensitivity to opioids or magnesium sulfate. Pregnancy and lactation. NSAID hypersensitivity or salicylate hypersensitivity. Patients with neuromuscular disease, such as myasthenia gravis. GIT bleeding and gastric ulcers. Bronchial asthma, exacerbations and AERD. Substances abuse and drug addiction.

Design outcomes

Primary

Measure	Time frame
Time taken to relieve pain	—

Secondary

Measure	Time frame
Complications related to the drugs	—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026